Jørgensen KA - Search Results

1

Detection of inhibitory anti-OKT3 antibodies in renal transplant patients.

Lamm LU, Mathiasen D, Povlsen JV, Pedersen EB, Birkeland SA, Jørgensen KA. Lamm LU, et al. Among authors: jorgensen ka. Transplant Proc. 1994 Jun;26(3):1730. Transplant Proc. 1994. PMID: 8030107 No abstract available.

2

Minnesota-ALG, forced diuresis, careful control of hydration, virus infection prophylaxis and dopamine infusion in human renal transplantation.

Jørgensen KA, Rohr N, Elbirk A, Svendsen V, Birkeland SA. Jørgensen KA, et al. Transplant Proc. 1992 Feb;24(1):358-9. Transplant Proc. 1992. PMID: 1539317 Clinical Trial. No abstract available.

3

Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.

Strate M, Jørgensen KA, Rohr N, Elbirk A, Svendsen V, Birkeland SA. Strate M, et al. Among authors: jorgensen ka. Transplant Proc. 1990 Feb;22(1):219-20. Transplant Proc. 1990. PMID: 2106739 No abstract available.

4

First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization.

Birkeland SA, Bach JF, Chatenoud L, Jørgensen KA, Strate M, Elbirk A, Rohr N, Svendsen V. Birkeland SA, et al. Among authors: jorgensen ka. Transplant Proc. 1990 Feb;22(1):221-2. Transplant Proc. 1990. PMID: 2106740 No abstract available.

5

Fine needle aspiration biopsy during and after OKT3.

Jørgensen KA, Strate M, Svendsen V, Rohr N, Elbirk A, Birkeland SA. Jørgensen KA, et al. Transplant Proc. 1989 Aug;21(4):3594-5. Transplant Proc. 1989. PMID: 2669254 No abstract available.

6

Severe neutropenia after renal transplantation and its reversal with granulocyte colony-stimulating factor.

Birkeland SA, Elbirk A, Rohr N, Jørgensen KA. Birkeland SA, et al. Among authors: jorgensen ka. Transplant Proc. 1994 Dec;26(6):3098-9. Transplant Proc. 1994. PMID: 7527945 Clinical Trial. No abstract available.

7

Chronic rejection in kidney transplant patients receiving cytomegalovirus prophylaxis with acyclovir.

Birkeland SA, Rohr N, Elbirk A, Jørgensen KA. Birkeland SA, et al. Among authors: jorgensen ka. Transplant Proc. 1995 Jun;27(3):2040-1. Transplant Proc. 1995. PMID: 7792878 No abstract available.

8

Optimization of cyclosporine monotherapy--long-term graft function.

Birkeland SA, Elbirk A, Rohr N, Jørgensen KA. Birkeland SA, et al. Among authors: jorgensen ka. Transplant Proc. 1994 Oct;26(5):2501-6. Transplant Proc. 1994. PMID: 7940767 No abstract available.

9

Cyclosporine monotherapy in children: long-term effect.

Birkeland SA, Elbirk A, Rohr N, Jørgensen KA. Birkeland SA, et al. Among authors: jorgensen ka. Transplant Proc. 1994 Oct;26(5):2610-6. Transplant Proc. 1994. PMID: 7940813 No abstract available.

10

Development of anti-OKT3 antibodies after OKT3 treatment.

Jensen PB, Birkeland SA, Rohrp N, Elbirk A, Jørgensen KA. Jensen PB, et al. Among authors: jorgensen ka. Scand J Urol Nephrol. 1996 Jun;30(3):227-30. doi: 10.3109/00365599609181304. Scand J Urol Nephrol. 1996. PMID: 8837256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters